Log In
BCIQ
Print this Print this
 

SYN-007

  Manage Alerts
Collapse Summary General Information
Company Synthetic Biologics Inc.
Description 
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentDiscovery
Standard IndicationIrritable bowel syndrome
Indication DetailsTreat & prevent irritable bowel syndrome (IBS)
Regulatory Designation
PartnerIntrexon Corp.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today